4/22
05:13 pm
bmy
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]
Low
Report
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]
4/22
03:58 pm
bmy
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]
Neutral
Report
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]
4/22
10:56 am
bmy
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/22
09:58 am
bmy
Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]
Low
Report
Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]
4/22
09:46 am
bmy
Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]
Neutral
Report
Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]
4/22
07:15 am
bmy
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster [Yahoo! Finance]
Low
Report
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster [Yahoo! Finance]
4/22
07:15 am
bmy
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer [Yahoo! Finance]
Low
Report
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer [Yahoo! Finance]
4/22
06:59 am
bmy
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Low
Report
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
4/22
06:59 am
bmy
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Low
Report
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
4/21
08:31 am
bmy
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt? [Yahoo! Finance]
Low
Report
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt? [Yahoo! Finance]
4/20
05:25 am
bmy
3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations [Yahoo! Finance]
Low
Report
3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations [Yahoo! Finance]
4/19
11:53 am
bmy
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies [Yahoo! Finance]
Low
Report
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies [Yahoo! Finance]
4/19
06:14 am
bmy
FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk [Seeking Alpha]
Low
Report
FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk [Seeking Alpha]
4/18
12:09 pm
bmy
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline [Yahoo! Finance]
Low
Report
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline [Yahoo! Finance]
4/18
11:18 am
bmy
Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Wells Fargo & Company from $51.00 to $52.00. They now have an "equal weight" rating on the stock.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Wells Fargo & Company from $51.00 to $52.00. They now have an "equal weight" rating on the stock.
4/18
07:23 am
bmy
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic [Yahoo! Finance]
Low
Report
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic [Yahoo! Finance]
4/17
11:56 am
bmy
Bristol-Myers Squibb: Market Pessimism Won't Last Forever [Seeking Alpha]
Low
Report
Bristol-Myers Squibb: Market Pessimism Won't Last Forever [Seeking Alpha]
4/17
09:37 am
bmy
2 High-Yield Dividend Stocks to Buy and Hold for 10 Years [Yahoo! Finance]
Low
Report
2 High-Yield Dividend Stocks to Buy and Hold for 10 Years [Yahoo! Finance]
4/15
11:02 pm
bmy
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
4/15
07:59 pm
bmy
Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
Low
Report
Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
4/15
10:27 am
bmy
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions [Yahoo! Finance]
Low
Report
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions [Yahoo! Finance]
4/15
09:38 am
bmy
Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF? [Yahoo! Finance]
Low
Report
Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF? [Yahoo! Finance]
4/12
02:45 pm
bmy
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
4/12
12:42 pm
bmy
Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) [Seeking Alpha]
Low
Report
Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) [Seeking Alpha]
4/12
10:19 am
bmy
Histone Deacetylase 6 Drug Pipeline Research Report 2024: Comprehensive Insights about 20+ Companies and 26+ Pipeline Drugs [Yahoo! Finance]
Low
Report
Histone Deacetylase 6 Drug Pipeline Research Report 2024: Comprehensive Insights about 20+ Companies and 26+ Pipeline Drugs [Yahoo! Finance]